237 related articles for article (PubMed ID: 17289839)
1. Characterization of the pH of folate receptor-containing endosomes and the rate of hydrolysis of internalized acid-labile folate-drug conjugates.
Yang J; Chen H; Vlahov IR; Cheng JX; Low PS
J Pharmacol Exp Ther; 2007 May; 321(2):462-8. PubMed ID: 17289839
[TBL] [Abstract][Full Text] [Related]
2. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
Chiu SJ; Marcucci G; Lee RJ
Anticancer Res; 2006; 26(2A):1049-56. PubMed ID: 16619505
[TBL] [Abstract][Full Text] [Related]
3. Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery.
Paulos CM; Reddy JA; Leamon CP; Turk MJ; Low PS
Mol Pharmacol; 2004 Dec; 66(6):1406-14. PubMed ID: 15371560
[TBL] [Abstract][Full Text] [Related]
4. Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue.
Leamon CP; Reddy JA; Vetzel M; Dorton R; Westrick E; Parker N; Wang Y; Vlahov I
Cancer Res; 2008 Dec; 68(23):9839-44. PubMed ID: 19047164
[TBL] [Abstract][Full Text] [Related]
5. Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.
Leamon CP; Cooper SR; Hardee GE
Bioconjug Chem; 2003; 14(4):738-47. PubMed ID: 12862426
[TBL] [Abstract][Full Text] [Related]
6. Measurement of endosome pH following folate receptor-mediated endocytosis.
Lee RJ; Wang S; Low PS
Biochim Biophys Acta; 1996 Jul; 1312(3):237-42. PubMed ID: 8703993
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging.
Yang J; Chen H; Vlahov IR; Cheng JX; Low PS
Proc Natl Acad Sci U S A; 2006 Sep; 103(37):13872-7. PubMed ID: 16950881
[TBL] [Abstract][Full Text] [Related]
8. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
9. Folate-mediated cell targeting and cytotoxicity using thermoresponsive microgels.
Nayak S; Lee H; Chmielewski J; Lyon LA
J Am Chem Soc; 2004 Aug; 126(33):10258-9. PubMed ID: 15315434
[TBL] [Abstract][Full Text] [Related]
10. The therapeutic efficiency of FP-PEA/TAM67 gene complexes via folate receptor-mediated endocytosis in a xenograft mice model.
Arote RB; Hwang SK; Lim HT; Kim TH; Jere D; Jiang HL; Kim YK; Cho MH; Cho CS
Biomaterials; 2010 Mar; 31(8):2435-45. PubMed ID: 20022105
[TBL] [Abstract][Full Text] [Related]
11. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.
Schroeder JE; Shweky I; Shmeeda H; Banin U; Gabizon A
J Control Release; 2007 Dec; 124(1-2):28-34. PubMed ID: 17928088
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of releasable folate-drug conjugates using a novel heterobifunctional disulfide-containing linker.
Satyam A
Bioorg Med Chem Lett; 2008 Jun; 18(11):3196-9. PubMed ID: 18468892
[TBL] [Abstract][Full Text] [Related]
13. Receptor-mediated gene delivery by folate-PEG-baculovirus in vitro.
Kim YK; Choi JY; Yoo MK; Jiang HL; Arote R; Je YH; Cho MH; Cho CS
J Biotechnol; 2007 Sep; 131(3):353-61. PubMed ID: 17727999
[TBL] [Abstract][Full Text] [Related]
14. Folate-conjugated micelles and their folate-receptor-mediated endocytosis.
Lu T; Sun J; Chen X; Zhang P; Jing X
Macromol Biosci; 2009 Nov; 9(11):1059-68. PubMed ID: 19688723
[TBL] [Abstract][Full Text] [Related]
15. Folate receptor endocytosis and trafficking.
Sabharanjak S; Mayor S
Adv Drug Deliv Rev; 2004 Apr; 56(8):1099-109. PubMed ID: 15094209
[TBL] [Abstract][Full Text] [Related]
16. Folate-targeted chemotherapy.
Leamon CP; Reddy JA
Adv Drug Deliv Rev; 2004 Apr; 56(8):1127-41. PubMed ID: 15094211
[TBL] [Abstract][Full Text] [Related]
17. Folate reception by vegetative Dictyostelium discoideum amoebae: distribution of receptors and trafficking of ligand.
Rifkin JL
Cell Motil Cytoskeleton; 2001 Feb; 48(2):121-9. PubMed ID: 11169764
[TBL] [Abstract][Full Text] [Related]
18. Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate.
Reddy JA; Westrick E; Santhapuram HK; Howard SJ; Miller ML; Vetzel M; Vlahov I; Chari RV; Goldmacher VS; Leamon CP
Cancer Res; 2007 Jul; 67(13):6376-82. PubMed ID: 17616697
[TBL] [Abstract][Full Text] [Related]
19. Receptor-mediated folate uptake is positively regulated by disruption of the actin cytoskeleton.
Lewis CM; Smith AK; Kamen BA
Cancer Res; 1998 Jul; 58(14):2952-6. PubMed ID: 9679952
[TBL] [Abstract][Full Text] [Related]
20. Folate receptor specific anti-tumor activity of folate-mitomycin conjugates.
Reddy JA; Westrick E; Vlahov I; Howard SJ; Santhapuram HK; Leamon CP
Cancer Chemother Pharmacol; 2006 Aug; 58(2):229-36. PubMed ID: 16331500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
